US1713401024 - Common Stock

**CHD** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 12 industry peers in the **Household Products** industry. **CHD** has only an average score on both its financial health and profitability. **CHD** is valied quite expensively at the moment, while it does show a decent growth rate.

In the past year **CHD** was profitable.

In the past year **CHD** had a positive cash flow from operations.

In the past 5 years **CHD** has always been profitable.

In the past 5 years **CHD** always reported a positive cash flow from operatings.

With a **Return On Invested Capital** value of **11.17%**, **CHD** perfoms like the industry average, outperforming **50.00%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **CHD** is in line with the industry average of **12.90%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.02% | ||

ROE | 10.79% | ||

ROIC | 11.17% |

ROA(3y)8.64%

ROA(5y)8.91%

ROE(3y)21.16%

ROE(5y)21.95%

ROIC(3y)13.09%

ROIC(5y)12.83%

In the last couple of years the **Profit Margin** of **CHD** has declined.

In the last couple of years the **Gross Margin** of **CHD** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 18.25% | ||

PM (TTM) | 7.57% | ||

GM | 43.45% |

OM growth 3Y-1.19%

OM growth 5Y-0.67%

PM growth 3Y-18.33%

PM growth 5Y-17.12%

GM growth 3Y-2.76%

GM growth 5Y-1.79%

Compared to 5 years ago, **CHD** has less shares outstanding

An Altman-Z score of **5.10** indicates that **CHD** is not in any danger for bankruptcy at the moment.

The Debt to FCF ratio of **CHD** is **2.55**, which is a good value as it means it would take **CHD**, **2.55** years of fcf income to pay off all of its debts.

Looking at the **Debt to Equity ratio**, with a value of **0.59**, **CHD** is in the better half of the industry, outperforming **75.00%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.59 | ||

Debt/FCF | 2.55 | ||

Altman-Z | 5.1 |

ROIC/WACC1.35

WACC8.29%

With a **Current ratio** value of **1.47**, **CHD** perfoms like the industry average, outperforming **41.67%** of the companies in the same industry.

A Quick Ratio of **0.90** indicates that **CHD** may have some problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **0.90**, **CHD** is in line with its industry, outperforming **41.67%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.47 | ||

Quick Ratio | 0.9 |

The earnings per share for **CHD** have decreased strongly by **-40.47%** in the last year.

EPS 1Y (TTM)-40.47%

EPS 3Y-12.17%

EPS 5Y-2.84%

EPS growth Q2Q-2.63%

Revenue 1Y (TTM)8.81%

Revenue growth 3Y7.25%

Revenue growth 5Y7.32%

Revenue growth Q2Q10.52%

Based on estimates for the next years, **CHD** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **20.88%** on average per year.

The **Revenue** is expected to grow by **4.29%** on average over the next years.

EPS Next Y90.15%

EPS Next 2Y43.64%

EPS Next 3Y30.44%

EPS Next 5Y20.88%

Revenue Next Year9.28%

Revenue Next 2Y6.42%

Revenue Next 3Y5.48%

Revenue Next 5Y4.29%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

Based on the **Price/Earnings** ratio of **54.29**, the valuation of **CHD** can be described as expensive.

83.33% of the companies in the same industry are cheaper than **CHD**, based on the **Price/Earnings** ratio.

When comparing the **Price/Earnings** ratio of **CHD** to the average of the S&P500 Index (**24.69**), we can say **CHD** is valued expensively.

Based on the **Price/Forward Earnings** ratio of **27.88**, the valuation of **CHD** can be described as expensive.

Based on the **Price/Forward Earnings** ratio, **CHD** is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.

When comparing the **Price/Forward Earnings** ratio of **CHD** to the average of the S&P500 Index (**19.79**), we can say **CHD** is valued slightly more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 54.29 | ||

Fwd PE | 27.88 |

Based on the **Enterprise Value to EBITDA** ratio, **CHD** is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **CHD** indicates a slightly more expensive valuation: **CHD** is more expensive than 75.00% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 25.19 | ||

EV/EBITDA | 19.64 |

PEG (NY)0.6

PEG (5Y)N/A

EPS Next 2Y43.64%

EPS Next 3Y30.44%

With a **Dividend Yield** of **1.16**, **CHD** pays less dividend than the S&P500 average, which is at **2.63**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.16% |

On average, the dividend of **CHD** grows each year by **6.67%**, which is quite nice.

Dividend Growth(5Y)6.67%

Div Incr Years10

Div Non Decr Years10

DP60.32%

EPS Next 2Y43.64%

EPS Next 3Y30.44%

**CHURCH & DWIGHT CO INC**

NYSE:CHD (11/30/2023, 5:40:00 PM)

After market: 96.6334 0 (0%)**96.63**

**+1.97 (+2.08%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryHousehold Products

Earnings (Last)11-03 2023-11-03/bmo

Earnings (Next)02-01 2024-02-01/amc

Inst Owners85.4%

Inst Owner Change-15.06%

Ins Owners0.09%

Ins Owner Change2.46%

Market Cap23.78B

Analysts67.2

Price Target99.72 (3.2%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.16% |

Dividend Growth(5Y)6.67%

DP60.32%

Div Incr Years10

Div Non Decr Years10

Ex-Date11-14 2023-11-14 (0.2725)

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)8.79%

Min EPS beat(2)6.37%

Max EPS beat(2)11.21%

EPS beat(4)3

Avg EPS beat(4)-47.41%

Min EPS beat(4)-210.5%

Max EPS beat(4)11.21%

Revenue beat(2)2

Avg Revenue beat(2)0.91%

Min Revenue beat(2)0.55%

Max Revenue beat(2)1.27%

Revenue beat(4)4

Avg Revenue beat(4)1.74%

Min Revenue beat(4)0.55%

Max Revenue beat(4)3.46%

PT rev (1m)-2.9%

PT rev (3m)-1.07%

EPS NQ rev (1m)-9.77%

EPS NQ rev (3m)-9.71%

EPS NY rev (1m)0%

EPS NY rev (3m)-0.11%

Revenue NQ rev (1m)-0.46%

Revenue NQ rev (3m)-0.46%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 54.29 | ||

Fwd PE | 27.88 | ||

P/S | 4.12 | ||

P/FCF | 25.19 | ||

P/OCF | 20.74 | ||

P/B | 5.87 | ||

P/tB | N/A | ||

EV/EBITDA | 19.64 |

EPS(TTM)1.78

EY1.84%

EPS(NY)3.47

Fwd EY3.59%

FCF(TTM)3.84

FCFY3.97%

OCF(TTM)4.66

OCFY4.82%

SpS23.47

BVpS16.46

TBVpS-6.99

PEG (NY)0.6

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.02% | ||

ROE | 10.79% | ||

ROCE | 14.03% | ||

ROIC | 11.17% | ||

ROICexc | 12.09% | ||

ROICexgc | 71.47% | ||

OM | 18.25% | ||

PM (TTM) | 7.57% | ||

GM | 43.45% | ||

FCFM | 16.34% |

ROA(3y)8.64%

ROA(5y)8.91%

ROE(3y)21.16%

ROE(5y)21.95%

ROIC(3y)13.09%

ROIC(5y)12.83%

ROICexc(3y)13.56%

ROICexc(5y)13.37%

ROICexgc(3y)247.67%

ROICexgc(5y)243.11%

ROCE(3y)17.06%

ROCE(5y)16.62%

ROICexcg growth 3Y-3.63%

ROICexcg growth 5Y-0.29%

ROICexc growth 3Y-1.1%

ROICexc growth 5Y0.05%

OM growth 3Y-1.19%

OM growth 5Y-0.67%

PM growth 3Y-18.33%

PM growth 5Y-17.12%

GM growth 3Y-2.76%

GM growth 5Y-1.79%

F-Score6

Asset Turnover0.66

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.59 | ||

Debt/FCF | 2.55 | ||

Debt/EBITDA | 1.88 | ||

Cap/Depr | 89.75% | ||

Cap/Sales | 3.5% | ||

Interest Coverage | 9.67 | ||

Cash Conversion | 89.6% | ||

Profit Quality | 215.92% | ||

Current Ratio | 1.47 | ||

Quick Ratio | 0.9 | ||

Altman-Z | 5.1 |

F-Score6

WACC8.29%

ROIC/WACC1.35

Cap/Depr(3y)62.67%

Cap/Depr(5y)54.52%

Cap/Sales(3y)2.55%

Cap/Sales(5y)2.16%

Profit Quality(3y)129.95%

Profit Quality(5y)128.38%

Growth

EPS 1Y (TTM)-40.47%

EPS 3Y-12.17%

EPS 5Y-2.84%

EPS growth Q2Q-2.63%

EPS Next Y90.15%

EPS Next 2Y43.64%

EPS Next 3Y30.44%

EPS Next 5Y20.88%

Revenue 1Y (TTM)8.81%

Revenue growth 3Y7.25%

Revenue growth 5Y7.32%

Revenue growth Q2Q10.52%

Revenue Next Year9.28%

Revenue Next 2Y6.42%

Revenue Next 3Y5.48%

Revenue Next 5Y4.29%

EBIT growth 1Y7.11%

EBIT growth 3Y5.97%

EBIT growth 5Y6.6%

EBIT Next Year29.79%

EBIT Next 3Y13.22%

EBIT Next 5Y9.49%

FCF growth 1Y28.03%

FCF growth 3Y-3.69%

FCF growth 5Y2.11%

OCF growth 1Y35.53%

OCF growth 3Y0.79%

OCF growth 5Y5.37%